Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255.SZ)
CNY 20.53
(3.53%)
CNY 20.53
(3.53%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 33.72 Million | 3.12 Million | 2.87 Million | -183.58 Million | -58.12 Million | 292.8 Million |
| Net Income | -1.24 Billion | 10.15 Million | 231.26 Million | 251.14 Million | 222.42 Million | 132.21 Million |
| Depreciation & Amortization | 74.7 Million | 56.93 Million | 55.8 Million | 55.28 Million | 52.29 Million | 45.54 Million |
| Deferred income taxes | -9.03 Million | 2.21 Million | 5.6 Million | -6.02 Million | -4.88 Million | 3.19 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 450.73 Million | -178.69 Million | -349.44 Million | -551.73 Million | -389.04 Million | -991.26 Thousand |
| Other non-cash items | 97.2 Million | 114.72 Million | 65.25 Million | 61.72 Million | 56.19 Million | 116.03 Million |
| Investing Cash Flow | -238.84 Million | -431.32 Million | -307.3 Million | -202.84 Million | 91.38 Million | -239.01 Million |
| Investments in PPE | -239.32 Million | -431.22 Million | -308.08 Million | -199.78 Million | -163.4 Million | -234.84 Million |
| Acquisitions | 22.36 Thousand | 725.00 | - | - | - | - |
| Investment purchases | -25 Million | - | - | - | - | -4.2 Million |
| Sales/Maturities of investments | 25 Million | - | - | - | 254.2 Million | - |
| Other Investing Activities | 447.59 Thousand | -104 Thousand | 777 Thousand | -3.06 Million | 587.99 Thousand | 31 Thousand |
| Financing Cash Flow | -294.94 Million | 653.44 Million | 342.96 Million | 291.66 Million | -211.29 Million | 130.66 Million |
| Debt repayment | -181.91 Million | -2.02 Billion | -1.18 Billion | -1.09 Billion | -954.49 Million | -610 Million |
| Dividends payments | -4.59 Million | -123.99 Million | -61.89 Million | -12.15 Million | -26.17 Million | -61.44 Million |
| Common Stock Repurchased | - | - | - | -120.01 Million | - | - |
| Common Stock Issuance | - | - | - | 120.01 Million | - | - |
| Other Financing Activities | -5.29 Million | 2.8 Billion | 1.58 Billion | 1.45 Billion | 814.8 Million | 802.1 Million |
| Accounts receivables | 284.65 Million | -97.06 Million | 91.52 Million | -90.31 Million | -14.39 Million | -1.39 Million |
| Accounts payables | 13.82 Million | 72.16 Million | -48.54 Million | 23.61 Million | -44.98 Million | 46.88 Million |
| Inventory | 161.28 Million | -156.01 Million | -398.02 Million | -479.01 Million | -324.78 Million | -49.67 Million |
| Other working capital | 4.79 Million | 2.21 Million | 5.6 Million | -6.02 Million | -4.88 Million | 48.68 Million |
| Cash at beginning of period | 727.89 Million | 489.68 Million | 454.65 Million | 551.17 Million | 728.62 Million | 541.12 Million |
| Cash at end of period | 230.85 Million | 727.89 Million | 489.68 Million | 454.65 Million | 551.17 Million | 728.62 Million |
| Capital Expenditure | -239.32 Million | -431.22 Million | -308.08 Million | -199.78 Million | -163.4 Million | -234.84 Million |
| Effect of forex changes on cash | 3.03 Million | 12.95 Million | -3.49 Million | -1.76 Million | 584.04 Thousand | 3.04 Million |
| Net cash flow / Change in cash | -497.03 Million | 238.2 Million | 35.03 Million | -96.52 Million | -177.45 Million | 187.5 Million |
| Free Cash Flow | -205.59 Million | -428.09 Million | -305.21 Million | -383.36 Million | -221.52 Million | 57.96 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 54.19 Million | 14.76 Million | -61.66 Million | -851.88 Million | -1.24 Billion | -232.45 Million |
| Depreciation & Amortization | - | 26.27 Million | 26.27 Million | 74.7 Million | 74.7 Million | -29.72 Million |
| Deferred income taxes | - | - | - | - | -9.03 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 5.48 Million | - | 445.94 Million | 450.73 Million | -74.61 Million |
| Other non-cash items | -96.69 Million | 90.41 Million | 175.6 Million | 488.32 Million | 97.2 Million | 378.51 Million |
| Investing Cash Flow | -26.68 Million | -43.41 Million | -48.18 Million | -46.34 Million | -238.84 Million | -49.62 Million |
| Investments in PPE | -24.36 Million | -45.34 Million | -48.19 Million | -47.22 Million | -239.32 Million | -49.49 Million |
| Acquisitions | - | - | - | 22.36 Thousand | 22.36 Thousand | - |
| Investment purchases | - | - | - | -25 Million | -25 Million | - |
| Sales/Maturities of investments | - | - | - | 25 Million | 25 Million | - |
| Other Investing Activities | -2.32 Million | 1.93 Million | 16 Thousand | 845.59 Thousand | 447.59 Thousand | -137 Thousand |
| Financing Cash Flow | 53.06 Million | -19.13 Million | 25.52 Million | -158.47 Million | -294.94 Million | -211.87 Million |
| Debt repayment | -80.04 Million | -523.34 Thousand | -62.62 Million | -124.92 Million | -181.91 Million | -535.26 Million |
| Dividends payments | -25.78 Million | -26.9 Million | -28.79 Million | -4.59 Million | -4.59 Million | -23.61 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.2 Million | -18.6 Million | -8.3 Million | -7.79 Million | -5.29 Million | 347 Million |
| Accounts receivables | - | -179.72 Million | - | 284.65 Million | 284.65 Million | -169.59 Million |
| Accounts payables | - | - | - | - | 13.82 Million | - |
| Inventory | - | 185.2 Million | - | 161.28 Million | 161.28 Million | 94.97 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 338.74 Million | 321.98 Million | 230.85 Million | 278.7 Million | 727.89 Million | 499.07 Million |
| Cash at end of period | 314.19 Million | 338.77 Million | 321.94 Million | 230.85 Million | 230.85 Million | 278.7 Million |
| Capital Expenditure | -24.36 Million | -45.34 Million | -48.19 Million | -47.22 Million | -239.32 Million | -49.49 Million |
| Effect of forex changes on cash | 12.72 Thousand | 439.71 Thousand | -208.03 Thousand | -112.21 Thousand | 3.03 Million | -588.53 Thousand |
| Net cash flow / Change in cash | -24.55 Million | 16.78 Million | 91.08 Million | -47.85 Million | -497.03 Million | -220.36 Million |
| Free Cash Flow | -66.86 Million | 33.56 Million | 65.74 Million | 109.86 Million | -205.59 Million | -7.76 Million |
0HJL
0966
WBS-PG
BARODARY
LINC
STSN